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Abstract 
Background: Very few studies focused on patients with severe infective endocarditis (IE) and multiple complications 
leading to Intensive Care Unit (ICU) admission. Studied primary outcomes depended on the series and multiple prog‑
nostic factors have been identified. Our goal was to determinate characteristics of patients, in‑hospital mortality and 
independent prognostic factors in an overall population of patients admitted to ICU for a left‑sided, definite, active 
and severe IE.
Methods: Retrospective study performed in 9 ICUs during an 11‑year period.
Results: Data of 248 patients (mean age = 62.4 ± 13.3 years; 63.7 % male) were studied. Native and prosthetic 
valves were involved in 195 and 53 patients, respectively. Causative pathogens, identified in 225 patients, were mainly 
streptococci (45.6 %) and staphylococci (43.4 %). On ICU admission, 127 patients exhibited extra‑cardiac involve‑
ment. Ninety‑five patients had one or more neurological complications, as followed: ischemic stroke (n = 66), cerebral 
hemorrhage (n = 31), meningitis (n = 16), brain abscess (n = 16), and intracranial mycotic aneurysm (n = 10). Criteria 
prompting to cardiac surgery appeared during ICU stay for 186 patients and between ICU and hospital discharges in 5 
patients. Due to contra‑indications, surgery required by IE was only performed during hospitalization in 125 patients. 
Moreover, surgery was considered adequate according to usual guidelines in 76 of 191 patients with indication(s) 
of valvular surgery: for patients with surgical procedure considered as emergency (n = 69), 17 surgical procedures 
underwent within the first 24 h following indication; for patients with urgent surgical indication (n = 102), surgery 
was performed during the first week following indication in 40 patients; finally, elective surgery (n = 20) was per‑
formed for 19 patients. During hospitalization, 103 (41.5 %) patients died. Four independent prognostic factors were 
identified: SAPS II > 35 (AOR = 2.604; 95 % CI: 1.320–5.136; p = 0.0058), SOFA > 8 (AOR = 3.327; 95 % CI: 1.697–6.521; 
p = 0.0005), IE due to methicillin resistant Staphylococcus aureus (AOR = 4.981; 95 %CI = 1.433–17.306; p = 0.0115) 
and native IE (AOR = 0.345; 95 % CI: 0.169–0.703; p = 0.0034).
Conclusions: Mortality in patients admitted to ICU for left‑sided IE remains high, especially in cases of endocarditis 
due to methicillin resistant Staphylococcus aureus, when organ failures occur and ICU scores are high.
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Background
The annual incidence of infective endocarditis (IE) in 
France at the beginning of the 21st century is around 33 
cases per million inhabitants [1]. Despite advances in 
diagnosis and medico-surgical treatment, the in-hospital 
mortality rate remains high, since ranging from 15 to 
22 % [1–3]. Most recent data underline that now Staphy-
lococcus aureus is the most common cause of IE and that 
approximately 50  % of patients underwent early valve 
replacement or repair [2, 3].
Open Access
*Correspondence:  oleroy@ch‑tourcoing.fr 
1 Service de Réanimation Médicale et Maladies Infectieuses, Hôpital 
Chatiliez, 135 rue du Président Coty, Tourcoing 59200, France
Full list of author information is available at the end of the article
Page 2 of 8Leroy et al. Ann. Intensive Care  (2015) 5:45 
Many complications can arise during the evolution 
of IE. Some are inaugural, the others come as the diag-
nosis has already been raised. Most of them can justify 
the admission of the patient in intensive care unit (ICU). 
Unfortunately, very few studies focused on patients with 
severe IE and multiple complications leading to ICU 
admission [4–7]. Therefore, we conducted a multicenter 
retrospective analysis of all consecutive critical left-sided 
IE patients to determinate characteristics of patients, in-




In 9 ICUs of 7 hospitals (Boulogne sur Mer, Douai, Dun-
kerque, Valenciennes, Lille, Roubaix, and Tourcoing) in 
Nord-Pas de Calais, an area from North of France, the 
charts of all consecutive patients admitted to the ICU 
with a diagnosis of IE between January 2002 and Decem-
ber 2012 were reviewed (OL, HG, SBi, ND, CD, SBe, 
PDu, CBG and SP). Information collected from medical 
records was anonymously entered into a database and 
reviewed for data entry errors and/or inconsistencies 
(OL, HG, SBi and SP). In agreement with French regula-
tions concerning observational studies that do not mod-
ify existing diagnosis or therapeutic strategies, no ethics 
committee approval was required to conduct the study.
Adult patients were enrolled in the study if they had 
a left-sided, definite, active and severe IE requiring ICU 
admission. IE involving mitral and/or aortic valves was 
defined as left-sided. Patients with both left- and right-
sided IE and left-sided IE associated with infection of a 
cardiac implantable electronic device (CIED) were con-
sidered as left-sided IE. Definite IE was defined according 
to modified Duke criteria [8]. Endocarditis was defined 
as active if the patient was admitted in ICU before or 
within the first 30  days of antimicrobial treatment. IE 
was considered as severe when associated with any of 
the following criteria: acute respiratory failure requiring 
mechanical ventilation, shock, Simplified Acute Physiol-
ogy Score (SAPS) II ≥20 and Sepsis-related Organ Fail-
ure Assessment (SOFA) score ≥3.
Patients with right-sided IE or infection of a cardiac 
implantable electronic device without left valves involve-
ment were not included as well as patients with IE 
acquired during ICU stay, or admitted in ICU after valve 
surgery for IE and, finally, those with possible IE.
Data collection and definitions
For each patient, IE was diagnosed when required modi-
fied Duke criteria were obtained. As all these criteria 
could not be present on ICU admission, there may be 
a delay between ICU admission and IE diagnosis that 
was determined. When IE was diagnosed, we collected 
for each patient information about demographics, pre-
existing comorbidities, condition at ICU admission, ini-
tial valve status, origin of infection, microbiological data, 
echocardiographic data, and extra-cardiac involvement 
revealed by initial work-up. As this study was retrospec-
tive, the initial work-up was not standardized and radio-
logical examinations were performed at the discretion 
of physicians. During the ICU stay, the antimicrobial 
treatment, the occurrence of complications, indications 
for surgery, timing of surgical procedure were recorded. 
Finally, outcome was evaluated.
Underlying conditions were evaluated by the Charl-
son score [9]. Severity of illness at ICU admission was 
assessed by the SAPS II, and SOFA score [10, 11]. Pros-
thetic valve IE was defined as infection occurring on any 
type of tissue or mechanical device. Hospital-acquired 
IE was defined as infection occurring more than 72  h 
after admission to the hospital or acquired in associa-
tion with a significant invasive procedure performed 
during a recent hospitalization within 8  weeks of this 
hospitalization [12]. Microbiological diagnosis was 
assessed according to modified Duke criteria. Echocar-
diographic data recorded were regurgitant valve, vegeta-
tion length and location. Follow-up examinations were 
performed to monitor vegetation size and to detect the 
occurrence of complications. Antimicrobial therapy was 
considered adequate if it included antibiotic(s) usually 
proposed by current guidelines [13]. IE complications 
on ICU admission such as congestive heart failure, septic 
shock, and extra-cardiac involvement mainly due to sys-
temic embolic events were defined according to current 
guidelines [13]. For neurological involvement, five com-
plications were distinguished according to the results of 
brain imaging (magnetic resonance imaging and/or com-
puterized tomography scanning) and cerebrospinal fluid 
analyses performed on initial work-up: ischemic stroke, 
cerebral hemorrhage, meningitis or meningeal reaction, 
brain abscess, and intracranial mycotic aneurysm.
Indications (heart failure, prevention of embolic events 
and uncontrolled infection) and timing of surgery (emer-
gency, urgent and elective) were defined by current 
guidelines [13]. Surgery was considered adequate when 
surgical procedure was performed accordingly to such 
guidelines. In-hospital mortality was defined as death 
occurring within the same hospitalization as ICU admis-
sion, regardless of its cause.
Statistical analysis
Descriptive analyses were performed to check and sum-
marize the data. Quantitative variables are reported 
as mean  ±  standard deviation. Qualitative variables 
are reported as number and percentage. Continuous 
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variables were compared using the Student’s t test. Cat-
egorical variables were compared using the Chi-square 
test or Fisher’s exact test when Chi square was not appro-
priate. Differences between groups were considered to 
be significant for variables yielding a p value ≤0.05. A 
stepwise logistic regression analysis was performed to 
identify risk factors associated with in-hospital mortality, 
regardless of its cause. In order to identify independent 
risk factors for mortality, variables were included in the 
multivariate model if the p value was ≤0.05 in bivariate 
analysis. Adjusted odds ratios (AOR) were computed 
using logistic regression analysis including the independ-
ent predictors of mortality.
All statistical analyses were performed using SAS soft-
ware, V9.1.
Results
During the study period, 352 patients with IE were 
admitted in one of the 9 ICUs of our group. We excluded 
104 patients for the following reasons: right-sided IE or 
infection of a cardiac implantable electronic device with-
out left valves involvement (n = 41); diagnosis of IE non 
definite (n = 34); non severe IE (n = 24); IE acquired dur-
ing ICU stay (n  =  5). Finally, 248 patients with severe, 
active, definite and left-sided IE were studied. Among 
them, two IE major criteria were present in 232 patients 
and one major criterion with 2 or 3 minor criteria was 
present in the remaining 16 patients. One hundred forty-
eight (59.7  %) patients were admitted in a tertiary care 
hospital with a cardiac surgery department (Lille) and 
100 (40.3 %) were admitted in a general hospital without 
any cardiac surgery department. The mean delay between 
ICU admission and IE diagnosis was 1.75  ±  3.74  days. 
Main patients’ characteristics on ICU admission and on 
IE diagnosis are summarized in Table 1.
Echocardiographic examinations revealed mitral 
vegetation(s) in 137 patients. Vegetations were large 
(>10 mm) in 67 patients and very large (>15 mm) in 41 
patients. Mitral regurgitation was severe (3 to 4+) in 56 
patients. One hundred and twenty-three patients exhib-
ited aortic vegetation(s). They were large and very large in 
51 and 24 patients, respectively. Aortic regurgitation was 
severe in 66 patients. An annular abscess was observed 
in 67 patients. Six patients had a pericardial effusion. 
Finally, the mean value of left ventricular ejection frac-
tion was 55.0 ± 11.6 %. It was <35 % in 16 patients, >35 % 
and <50 % in 82, >50 % in 144, and finally not determined 
in 6.
Causative pathogen was identified in 225 (90.7  %) 
patients. Blood and leaflet cultures were positive in 222 
and 25 cases, respectively. Two hundred and thirty-five 
causative pathogens were identified. IE was polymicrobial 
in 9 patients. The most common pathogens were strepto-
cocci (45.6 %), and staphylococci (43.4 %) (Table 2).
On ICU admission and during the initial course of IE, 
127 patients (51.2  %) exhibited extra-cardiac involve-
ment. Main involved organ was the central nervous 
system. According to neurological investigations per-
formed on 184 patients (74.2  %) (computerized tomog-
raphy scanning n  =  160, magnetic resonance imaging, 
Table 1 Main patients’ characteristics on  ICU admission 
and on IE diagnosis
The results are given as n (%) or median ± SD
When indicated SAPS II Simplified Acute Physiologic Score II, SOFA sepsis-related 
organ failure assessment score, CIED cardiac implantable electronic device
Patients’ characteristics
Age (years) 62.4 ± 13.3
Sex: M/F 158/90
Charlson score 4.58 ± 2.70
SAPS II 36.7 ± 16.7
SOFA score 7.0 ± 3.7
Main indications for ICU admission
 Septic shock 54 (21.8)
 Severe valvular regurgitation 46 (18.55)
 Cardiogenic shock 39 (15.7)
 Acute renal failure 36 (14.5)
 Acute respiratory failure requiring mechanical 
ventilation
28 (11.3)
 Neurological complications 17 (6.85)
Community‑acquired/hospital‑acquired IE 215 (86.7)/33 (13.3)






 Multiple valve involvement 66
  Aortic plus mitral valves 53
  Aortic plus tricuspid valves 3
  Aortic plus pulmonary valves 1
  Aortic plus mitral plus tricuspid valves plus CIED 1
  Aortic plus mitral valves plus CIED 3
  Aortic valve plus CIED 1
  Mitral plus tricuspid valves 3
  Mitral plus tricuspid valves plus CIED 1
Portal of entry of IE 126 (50.8)
 Skin or soft tissue 36
 Dental 24
 Upper respiratory tract 9
 Genitourinary tract 13
 Digestive tract 23
 Intra‑venous drug abuse 2
 Cardiovascular procedure or vascular access 19
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and cerebrospinal fluid analyses n = 25), 139 neurologi-
cal complications were found in 95 patients, as followed: 
ischemic stroke (n = 66), cerebral hemorrhage (n = 31), 
meningitis (n = 16), brain abscess (n = 16), and intracra-
nial mycotic aneurysm (n = 10). Moreover, according to 
chest (n = 105), bone (n = 75) and abdominal (n = 144) 
computerized tomography scans, abdominal ultrasonog-
raphy (n =  34), lung (n =  8) and bone (n =  13) scans, 
and bone magnetic resonance imaging (n = 24), systemic 
embolic or metastatic infective events involving spleen 
(n = 33), bone and joints (n = 22), kidneys (n = 21), lung 
(n = 3) and liver (n = 3) were found.
All patients received an antimicrobial treatment. This 
treatment was adequate in 206 (83.1  %) patients. During 
ICU stay, surgery was indicated for 186 (75 %) patients. The 
timing of surgical procedure was considered as emergency 
in 69 (37.1 %) patients, urgent in 102 (54.9 %) patients and 
elective in 15 (8 %) patients. Main indications and contra-
indications for surgery are summarized in Table  3. Sur-
gery was performed in 99 patients during the ICU stay 
(Table 4). Among the 101 patients without contra-indica-
tions to surgery, 84 (83.2  %) patients underwent surgery 
during ICU stay. Among the 85 patients with contra-indi-
cations, surgery was nonetheless performed in 15 (17.6 %) 
patients. In these latter patients, contra-indications were 
hemorrhagic stroke (n = 10), multiple organ failure (n = 3) 
and severe underlying diseases (n = 2). It could be noticed 
that only two of them, exhibiting multiple organ failure, 
died. Moreover, 21 patients with surgery indicated during 
ICU stay and 5 patients with ultimately appeared indica-
tion underwent surgical procedure between ICU and hos-
pital discharges. Thus, during hospitalization, a surgical 
procedure was required by IE in 191 patients and was per-
formed for 125 patients. Surgical procedure was required 
more often for patients admitted in a tertiary care hospital 
with a cardiac surgery department (n = 127/148) than for 
admitted in a general hospital without any cardiac surgery 
department (n = 64/100) (p < 0.001).
For patients with surgical procedure considered as 
emergency (n  =  69), 17 surgical procedure underwent 
within the first 24  h following indication. For patients 
with urgent surgical indication (n  =  102), surgery was 
performed during the first week following indication in 
40 patients. Finally elective surgery (n  =  20) was per-
formed for 19 patients. So, surgery was considered 
adequate according to usual guidelines in 76 of 191 
(39.8  %) patients with indication(s) of valvular surgery. 
Surgery was more often adequate for patients admitted 
in a tertiary care hospital with a cardiac surgery depart-
ment (n = 57/127) than for patients in a general hospi-
tal without any cardiac surgery department (n = 19/64) 
(p < 0.001).
Table 2 Causative microorganisms (n  =  235) isolated 
from cases of active IE
Micro organism N (%)
Streptococcus spp. 107 (45.6)
 Beta‑haemolytic Streptococcus (groups A, B, C and G) 27
 Oral Streptococcus 24
 Enterococcus spp. 24
 Group D Streptococcus 19
 Streptococcus pneumoniae 13
Staphylococcus aureus 90 (38.3)
 Methicillin‑susceptible 74
 Methicillin‑resistant 16
Coagulase‑negative Staphylococcus 12 (5.1)
Gram‑negative bacilli 14 (6.0)
 Haemophilus influenzae 2
 Enterobacteriaceae 11
 Pasteurella multocida 1
Gram positive bacilli 1 (0.4)
Candida spp. and Aspergillus spp. 4 (1.7)
Other 7 (3.05)
Table 3 Main Indications and contra-indications for valvular surgery during ICU stay
Timing of surgery Indications Number of patients  
with contra-indications
Contra-indications
Emergency n = 69 Cardiogenic shock n = 41
Refractory pulmonary oedema n = 28
33 (47.8 %) Multiple organ failure n = 16
Hemorrhagic stroke n = 8
Severe underlying diseases n = 7
Risk of extra cerebral hemorrhage n = 2
Urgent n = 102 Very large vegetations = 43
Large vegetations and embolic episodes  
n = 21
Annular abscess n = 27
Uncontrolled infection n = 8
Severe acute regurgitation n = 3
50 (49 %) Risk of cerebral hemorrhage n = 22
Multiple organ failure n = 16
Severe underlying diseases n = 11
Risk of extra cerebral haemorrhage n = 1
Elective n = 15 Severe regurgitation without heart failure  
n = 12
Severe prosthetic dehiscence n = 3
2 (13.3 %) Severe underlying diseases n = 1
Multiple organ failure n = 1
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During hospitalization, 103 (41.5 %) patients died. Main 
significant factors associated with in-hospital mortality in 
bivariate analysis are reported in Table 5. Factors assessing 
severity of underlying diseases and/or IE on ICU admis-
sion were associated with a significant increased mortal-
ity as well as prosthetic and staphylococcal IE. Conversely, 
native IE, IE due to Streptococcus and therapeutic meas-
ures such as surgery during ICU stay, adequate surgery 
and adequate antimicrobial treatment were associated 
with a significant decreased mortality. Multivariate analy-
sis including all significant variables in bivariate analysis 
(p < 0.05), except surgery during ICU stay, surgery (over-
all) and adequate surgery, identified 4 independent prog-
nostic factors. They were SAPS II > 35 (AOR = 2.604; 95 % 
CI: 1.320–5.136; p =  0.0058), SOFA  >  8 (AOR =  3.327; 
95  % CI: 1.697–6.521; p  =  0.0005), IE due to methi-
cillin resistant Staphylococcus aureus (AOR  =  4.981; 
95 %CI = 1.433–17.306; p = 0.0115) and native valve IE 
(AOR = 0.345; 95 % CI: 0.169–0.703; p = 0.0034).
To focus on the 16 patients with IE due to methicillin 
resistant Staphylococcus aureus, we could add that 12 
had a native valve IE. Infection was hospital-acquired in 8 
cases. Main portal of entry were skin or soft tissue (n = 4) 
and vascular access infections (n = 4). On ICU admission, 
the mean SAPS II was 44.6 ± 23.7 and 7 patients exhibited 
septic shock. Annular abscess was observed in 7 patients 
and neurological complications occurred in 7 patients. 
Antimicrobial treatment was considered inadequate in 
4 patients (vancomycin without gentamicin in 2 cases of 
native valve IE and vancomycin  +  gentamicin without 
rifampin in 2 cases of prosthetic valve IE). Surgery was 
indicated for 11 patients (emergency n = 3; urgent n = 7; 
elective n = 1) but was adequate in only 3 patients. Dur-
ing hospitalization, 12 patients died (in ICU, n = 10).
Discussion
We report the results of a retrospective multicenter study 
on 248 patients with severe, active, definite and left-sided 
IE requiring ICU admission. Main causative pathogens 
are equally represented by streptococci and staphylo-
cocci. During ICU stay, surgery was indicated for 75 % of 
patients but only 53 % of them underwent surgical pro-
cedures during ICU stay. Overall in-hospital mortality 
was 41.5 %. Independent factors associated with progno-
sis were SAPS II on ICU admission >35, SOFA on ICU 
admission >8, IE due to methicillin resistant Staphylococ-
cus aureus and native IE.
Current data suggest that staphylococci are the most 
common causative pathogens of IE. In the overall popu-
lation of adults with definite IE admitted to hospital, S. 
aureus accounted for 26.6–36.2  % of causal agents [2, 
14]. In series including only adult patients admitted to 
ICU with infective endocarditis, S. aureus represented 
45–56  % of identified causative organisms [4, 7]. Our 
results could appear surprising since even if staphylo-
cocci are involved in 43.4 % of patients, they are less fre-
quent causative organisms than streptococci involved 
in 45.6 % of patients. However, they are similar to those 
reported more than 10 years ago by Hoen et al. in France 
and Hasbun et al. in USA [15, 16]. In these series having 
included patients in 1999 and between 1990 and 2000, 
streptococci are involved in 48 and 58 %, respectively. We 
have no clear explanation about these microbiological 
differences between our study and those reporting data 
from patients admitted in ICU [4, 7]. Nevertheless, stud-
ied patients could be a little different. In the study from 
Mourvillier and colleagues, prosthetic valve IE are more 
frequent than in our series (40.6 vs. 21.4  %) and, if we 
focused only on native IE, streptococci and staphylococci 
are equally involved as causative organisms [4]. In the 
study reported by Samol and colleagues, 31 % of patients 
had right-sided endocarditis and it is well known that S. 
aureus is then the most common pathogen [7, 17].
In our study, a surgical procedure required by IE 
was performed during hospitalization for 125 patients 
(50.4 %). In series focusing on patients admitted to ICU 





Number of patients  
with surgery performed  
during ICU stay
In hospital  
mortality n (%)
Number of patients  




Patients with contra‑indications to surgery n = 85
 Emergency 33 6 1 (16.7 %) 27 25 (92.6 %)
 Urgent 50 8 1 (12.5 %) 42 30 (71.4 %)
 Elective 2 1 0 1 0
Patients without contra‑indications to surgery n = 101
 Emergency 36 36 6 (16.6 %) 0 0
 Urgent 52 41 11 (21.2 %) 11 0
 Elective 13 7 0 6 2 (33.3 %)
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for IE, 35–52  % of patients underwent surgery [4, 6, 7]. 
Rather than these gross percentages, an important point 
is, in our mind, the percentage of performed surgical pro-
cedures among patients for which indications for surgery 
emerge during ICU stay. Literature data are unfortunately 
scarce. In our series, surgery was indicated for 186 (75 %) 
patients but only 99 (53  %) of them underwent surgical 
procedures during ICU stay. In the study reported by 
Mirabel et  al., the percentage appears higher since 100 
of 158 patients with recommended surgical procedure 
underwent surgery [6]. Unfortunately, in this series, the 
timing of surgical procedure (emergency, urgent and 
elective) was only reported for patients undergoing sur-
gery. So, it was not possible to determine the adequacy 
of surgery according to the timing, and consequently, 
to compare these results with ours. It’s a shame because 
it would have been interesting to known if the low per-
centage of adequate surgery observed in our series when 
timing was considered as emergency or urgent was also 
observed in other studies. In our series, it could be also 
noticed that among the 85 patients with contra-indica-
tions to surgery, 15 underwent nonetheless surgery and 
that 13 of them survived. Finally, surgery was more often 
adequate for patients admitted in a tertiary care hospital 
with a cardiac surgery department than for patients in 
a general hospital without any cardiac surgery depart-
ment. Such a result reinforces recent recommendations 
for referring complicated IE patients to tertiary care hos-
pitals in which a collaborative approach of IE involving 
notably a cardiac surgeon is possible [18].
The impact of surgery on IE prognosis was the subject 
of numerous studies. Despite some conflicting results, 
surgical therapy appears most often associated with an 
improved early and late survival both in the overall popu-
lation of patients than in patients admitted to ICU [4, 6, 
7, 19–25]. In our series, in-hospital mortality was 41.5 %. 
In similar series, mortality rates varied between 30 and 
45 %, and apart surgery, identified independent prognos-
tic factors were septic shock, cerebral emboli, immuno-
suppression, neurological failure, severe comorbidities, 
S. aureus IE and SAPS II [4, 5, 7]. Most of these factors 
appear in our series as significant prognostic factors in 
bi variate analysis. Among them, we could notice that IE 
due to Streptococcus spp. were associated with a lower 
mortality than IE due to Staphylococcus spp. and that 
adequacy of antimicrobial and of surgical treatment also 
appeared as factors associated with survival. However, in 
our study, we willingly chose to not enter in multivariate 
Table 5 Bivariate analysis of risk factors for in-hospital mortality
MSSA methicillin-susceptible Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus
Factor Survivors n = 145 Non-survivors n = 103 p
Charlson score 4.18 ± 2.80 5.15 ± 2.46 0.003
SAPS II 30.99 ± 13.16 44.60 ± 17.95 <0.0001
SAPS II > 35 43 (38.4 %) 69 (61.6 %) <0.0001
SOFA score 5.65 ± 2.77 8.93 ± 3.91 <0.0001
SOFA score >8 30 (33 %) 61 (67 %) <0.0001
Glasgow Coma Score <9 7 (17.9 %) 32 (82.1 %) <0.0001
ICU admission for septic shock 17 (31.5 %) 37 (68.5 %) <0.0001
ICU admission for cardiogenic shock 16 (41 %) 23 (59 %) 0.016
ICU admission for acute respiratory failure 22 (78.6 %) 6 (21.4 %) 0.02
ICU admission for severe valvular regurgitation 40 (87 %) 6 (13 %) <0.0001
Mitral IE 80 (52.6 %) 72 (47.4 %) 0.02
Native IE 121 (62.05 %) 74 (37.95 %) 0.03
Prosthetic IE 24 (45.3 %) 29 (54.7 %) 0.03
Annular abscess 31 (46.3 %) 36 (53.7 %) 0.02
Severe aortic regurgitation 50 (75.8 %) 16 (24.2 %) 0.0009
Left ventricular ejection fraction (%) 57 ± 11 52 ± 13 0.005
IE due to Streptococcus spp. 72 (67.3 %) 35 (32.7 %) 0.01
IE due to MSSA 36 (48.70 %) 38 (51.3 %) 0.04
IE due to MRSA 4 (25 %) 12 (75 %) 0.005
Adequate antimicrobial treatment 127 (61.7 %) 79 (38.3 %) 0.02
Surgery during ICU stay 80 (80.8 %) 19 (19.2 %) <0.0001
Surgery (overall) 102 (81.6 %) 23 (18.4 %) <0.0001
Adequate surgery 65 (85.5 %) 11 (14.5 %) <0.0001
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analysis the significant factors about surgery identified 
in bivariate analysis (surgery during ICU stay, surgery 
and adequate surgery) since the overall population was 
not affected by these prognostic factors. Our multivari-
ate analysis identified 4 independent factors. They were 
SAPS II > 35 (AOR = 2.604), SOFA > 8 (AOR = 3.327), 
IE due to methicillin resistant Staphylococcus aureus 
(AOR  =  4.981) and native IE (AOR  =  0.345). The fact 
that scores assessing severity and/or organ failure on ICU 
admission are independent prognostic factors is not sur-
prising since they are usually found in all studies focus-
ing on prognostic of ICU patients. The protective role of 
the native character of endocarditis is not, in our opin-
ion, surprising since the deleterious role of the prosthetic 
character of endocarditis is well known [3]. In example, 
in the study reported by Murdoch et  al. including 2781 
patients from the International Collaboration on Endo-
carditis–Prospective Cohort Study, prosthetic valve 
involvement appears as an independent factor associated 
with mortality [2]. The deleterious role of an infection 
due to methicillin-resistant Staphylococcus aureus could 
appear more surprising since it has not yet been found 
in previous studies. However, in our opinion, it was not 
really studied. In the study reported by Murdoch, 869 
patients exhibited a S. aureus IE but no data about sen-
sitivity to methicillin was reported [2]. In a French study 
reporting data about 497 adults with Duke-Li–definite 
IE, 180 patients had a S. aureus IE [14]. Resistance to 
methicillin was observed in 13.6  % of S. aureus. Unfor-
tunately, no data about impact of resistance to methicil-
lin were provided. Finally, to the best of our knowledge, 
the study reported by Fowler et al. is one of the few stud-
ies providing prognostic data according to sensitivity to 
methicillin of S. aureus [26]. Among 1779 patients from 
the International Collaboration on Endocarditis–Pro-
spective Cohort Study, the authors identified 424 patients 
with definite S aureus IE and no history of active IDU. 
Among them, 141 (33.3 %) were infected with methicillin 
resistant S. aureus. These patients tended to have higher 
mortality (29.8 vs. 23.3 %; p = 0.14) than those infected 
with a methicillin susceptible strain.
Our study has several limitations. First, all data were 
collected retrospectively. Second, it was a multicenter 
study. As a consequence of these 2 points, diagnostic 
methods, screening for complications and therapeutic 
measures were not standardized. Moreover, only one of 
the seven hospitals participating in the study had cardiac 
surgery units. It could thus be assumed that the access to 
cardiac surgery has not been the same for all patients, the 
most distant patients from surgical units being the least 
likely to benefit from emergency or urgent surgery. Simi-
larly, a multidisciplinary approach could not be optimal 
for these later patients. Third, independent prognostic 
factors were identified by a stepwise logistic regression 
analysis. No case–control analysis was performed to 
evaluate the performance of identified factors. Fourth, 
our analysis was unable to establish a causal relationship 
between some therapeutic measures such as adequate 
antimicrobial treatment and survival. In a previous work, 
we demonstrated that such a treatment was an inde-
pendent prognostic factor associated with survival [27]. 
Finally, we have only information on in-hospital mortality 
and long-term outcome was unknown.
In conclusion, mortality in patients admitted to ICU for 
left-sided IE remains high, especially in cases of endocar-
ditis due to methicillin resistant Staphylococcus aureus 
and when organ failures occur and ICU scores are high.
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